Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: A retrospective study

Journal of Rheumatology

Volumn 37, Issue 11, 2010, Pages 2232-2236

  Mazzantini, Maurizio ^a   Talarico, Rosaria ^a   Doveri, Marica ^a   Consensi, Arianna ^a   Cazzato, Massimiliano ^a   Bazzichi, Laura ^a   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Comorbidity; Drug toxicity; Glucocorticoids; Rheumatoid arthritis

Indexed keywords

GLUCOCORTICOID; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CATARACT; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; HYPERTENSION; INFECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; COMORBIDITY; FEMALE; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; MALE; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78149239238     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100461     Document Type: Article

References (17)

1. Kirwan JR, Bijlsma JWJ, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev 2007;1:CD006356.
2. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
3. Hickling P, Jacoby RK, Kirwan JR. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. Br J Rheumatol 1998;37:930-6.
4. Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:3371-80.
5. van Everdingen AA, Jacobs JW, Siewertsz van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
6. Capell HA, Madhok R, Hunter JA, Porter D, Morrison E, Larkin J, et al. Lack of radiological and clinical benefit over two years of low-dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis 2004;63:797-803.
7. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004;141:764-70.
8. Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Guttham S. Use of oral corticosteroid and the risk of acute myocardial infarction. Atherosclerosis 2007;192:376-83.
9. Södergren A, Stegmayr B, Ohman ML, Wållberg-Jonsson S. Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis. Clin Exp Rheumatol 2009;27:641-4.
10. Lévy L, Fautrel B, Barnetche T, Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 2008;26:673-9.
11. Kirwan JR. Systemic corticosteroid in rheumatology. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed. Philadelphia: Mosby; 2003:385-92.
12. World Health Organization. Guidelines for preclinical evaluation and clinical trials in osteoporosis. Geneva: WHO; 1998.
13. Ravidran V, Rachapalli S, Choy EH. Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis. Rheumatology 2009;48:807-11.
14. Choy EH, Kingsley GH, Khoshaba B, Pipitone N, Scott DL; Methylprednisolone Study Group. A two-year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs. Ann Rheum Dis 2005;64:1288-93.
15. Chamberlain MA, Keenan J. The effect of low dose prednisolone compared with placebo on function and on the hypothalamic pituitary adrenal axis in patients with rheumatoid arthritis. Rheumatol Rehabil 1976;15:17-23.
16. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007;56:820-30.
17. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104-12.